1. Enzyme therapy: The enzyme PEG L-Asparaginase degrades asparagine, which some cancer cells need for growth and survival.
2. All Medical Care: It is a typical course of treatment for All, a leukaemia that affects white blood cells.
3. Reduced Injection Frequency: When L-Asparaginase is PEGylated (conjugated with polyethylene glycol), its half-life is extended, allowing for less frequent injections than when L-Asparaginase is administered naturally.
4. PEG L-asparaginase is often administered intramuscularly or intravenously, typically once every few weeks as part of a therapeutic regimen.
5. Combination Therapy: To improve the efficacy of treatment, it is frequently used in conjunction with other chemotherapy medications.
6. PEG L-asparaginase is frequently utilised in the treatment of paediatric ALL due to its potency against children leukaemia.
7. Reducing the likelihood of hypersensitivity reactions: PEGylation lowers the potential for hypersensitivity responses when using native L-asparaginase.
1. Hypersensitivity Reactions: Although less frequently than with native L-asparaginase, certain patients may nevertheless have hypersensitivity reactions to PEG L-asparaginase.
2. PEG L-asparaginase can sometimes have toxic effects on the liver.
3. Pancreatitis: This condition can result in pancreatic inflammation and cause stomach pain, nausea, and vomiting.
4. PEG L-asparaginase can interfere with blood clotting factors, raising the risk of bleeding and bruising. Coagulation abnormalities.
5. Patients may feel weak or worn out while receiving treatment.
6. Blood Cell Count Changes: PEG L-Asparaginase can interfere with bone marrow function, which can result in a reduction in platelets, red blood cells, and white blood cells.
7. Infection risk is increased by PEG L-asparaginase's ability to depress the immune system, which results in fever.
Prior to beginning PEG L-Asparaginase therapy, patients must address any risks and adverse effects with their healthcare physician. The management of adverse effects and the safe and efficient use of this medicine can be achieved through routine monitoring and appropriate medical supervision during therapy.
MEHADIA TRADELINKS
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |